IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences granted non-qualified stock options covering an aggregate 99,600 shares to four newly hired employees on October 29, 2026. The grants were made under the 2023 Employment Inducement Incentive Award Plan pursuant to Nasdaq Listing Rule 5635(c)(4), with an exercise price of $32.89 per share, a 10-year term, and standard four-year vesting.
Key figures
- Offering Price
- 32.89
- Shares Offered
- 99600
- Vest schedule
- 25% at 1 year, remaining 75% monthly over 3 years
- Option term years
- 10
- Employees receiving grants
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.